发明名称 Mutant G-CSF fusion protein, and preparation and use thereof
摘要 The present invention relates to a mutant G-CSF fusion protein. The mutant G-CSF fusion protein is a fusion protein having the activity of stimulating the proliferation of neutrophilic granulocytes, and having a basic structure of G-CSF/carrier protein or carrier protein/G-CSF; wherein the G-CSF moiety comprises multipoint substitutions thus resulting in changes in biological activity and binding affinity. Compared with existing products, the mutant G-CSF fusion protein in the present invention has longer half-life and higher biological activity. Administration of the pharmaceutical preparation containing this mutant G-CSF fusion protein could be used in the treating neutropenia.
申请公布号 US8785597(B2) 申请公布日期 2014.07.22
申请号 US201013575752 申请日期 2010.06.30
申请人 Jiangsu T-Mab Biopharma Co., Ltd. 发明人 Wen Xiaofang;Wu Yiliang;Wang Yefei;Yang Zhiyu;Fan Min;Wang Yujiao;Fang Xiaochun;Lu You
分类号 C07K1/00;C12P21/04;C12N15/00;C12N5/00;A61K38/18 主分类号 C07K1/00
代理机构 Sinorica, LLC 代理人 Chow Ming;Sinorica, LLC
主权项 1. A mutant G-CSF fusion protein, comprising a G-CSF moiety and a carrier protein; said G-CSF moiety being derived from a human G-CSF protein with its amino acid sequence set forth in SEP ID NO: 1; said G-CSF moiety comprising at least one of the mutations of K34H, L35I, K40H and L41I; and said mutant G-CSF fusion protein stimulating proliferations of neutrophilic granulocytes.
地址 Jiangsu Province CN